Nifty Pharma maintains gaining spree; Cadila, Lupin led the pack

Divis Lab also gained over 1% to lift performance. Torrent Pharma slipped 1% to drag.

Apr 08, 2021 01:04 IST India Infoline News Service

Bull run Faster
Nifty Pharma Index continues to ride with markets bulls by advancing over 0.7% on Thursday. The Index is witnessing buying sentiment amid surging Covid-19 cases in the country and progression on drugs and vaccines to counter the pandemic.

Cadila led the gains while Lupin and Divis Lab also lifted the performance. Torrent Pharma dragged the sector.

At around 1.15 pm, Nifty Pharma was trading at 12,700.25 up 83.90 points or 0.67%, touching a high of 12,739.05 during intraday trade on Thursday.

Cadila Healthcare rose 2.67% to Rs474.05 per piece after the pharma company announced that it has received final approval from the USFDA to market Macitentan Tablets, 10 mg.

Lupin was 1.87% higher at Rs1,053.50 per piece. Divis Lab continued forward moment by advacing 1.18% at Rs3,742.65 per piece.

Auro Pharma was 0.78% up despite trimming few gains. Dr Reddy's also gained 0.69% while Cipla was also 0.62% on the upside. Sun Pharma was also marginally higher.

Alkem Lab and Biocon traded marginally lower and it was Torrent Pharma that emerged the biggest laggard. Torrent Pharma was down 1% at Rs2,551.70 per piece. 

Related Story

Open Free Demat Account (Rs699)